Related Experiment Video
Updated: Mar 27, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
An accessible pharmacodynamic transcriptional biomarker for notch target engagement
K Q Tanis1, A A Podtelezhnikov1, S C Blackman1
1Merck & Co., Kenilworth, New Jersey, USA.
Abstract:
γ-Secretase mediates amyloid production in Alzheimer's disease (AD) and oncogenic activity of Notch. γ-Secretase inhibitors (GSIs) are thus of interest for AD and oncology. A peripheral biomarker of Notch activity would aid determination of the therapeutic window and dosing regimen for GSIs, given toxicities associated with chronic Notch inhibition. This study examined the effects of GSI MK-0752 on blood and hair follicle transcriptomes in healthy volunteers. The effects of a structurally diverse GSI on rhesus blood and hair follicles were also compared. Significant dose-related effects of MK-0752 on transcription were observed in hair follicles, but not blood. The GSI biomarker identified in follicles exhibited 100% accuracy in a clinical test cohort, and was regulated in rhesus by a structurally diverse GSI. This study identified a translatable, accessible pharmacodynamic biomarker of GSI target engagement and provides proof of concept of hair follicle RNA as a translatable biomarker source.
Insights
Researchers identified a novel biomarker in hair follicles to monitor Notch pathway activity. This biomarker accurately reflects the effects of gamma-secretase inhibitors (GSIs), aiding safe drug development for Alzheimer's disease and cancer.
Area of Science:
- Pharmacology
- Biomarker Discovery
- Molecular Biology
Background:
- Gamma-secretase is implicated in Alzheimer's disease (AD) amyloid production and Notch signaling's oncogenic roles.
- Gamma-secretase inhibitors (GSIs) are investigated for AD and oncology, but toxicities necessitate monitoring.
- A peripheral biomarker for Notch activity is crucial for determining GSI therapeutic windows and dosing.
Purpose of the Study:
- To investigate the effects of GSI MK-0752 on human blood and hair follicle transcriptomes.
- To identify a translatable pharmacodynamic biomarker for GSI target engagement.
- To compare GSI effects on rhesus blood and hair follicles.
Main Methods:
- Analysis of blood and hair follicle transcriptomes in healthy volunteers treated with GSI MK-0752.
- Dose-response assessment of GSI effects on gene transcription.
- Comparison of GSI activity in human and rhesus models.
- Validation of the identified biomarker in a clinical cohort.
Main Results:
- MK-0752 significantly impacted hair follicle transcription in a dose-dependent manner, unlike blood.
- A GSI biomarker identified in hair follicles showed 100% accuracy in a clinical test cohort.
- The biomarker was also regulated by a different GSI in rhesus models, demonstrating translatability.
Conclusions:
- Hair follicle RNA serves as a translatable and accessible source for pharmacodynamic biomarkers.
- This study identified a reliable biomarker for GSI target engagement, enabling better therapeutic monitoring.
- The findings support the use of hair follicles for assessing GSI activity and optimizing treatment strategies.
More Related Videos
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
12:29Identifying Transcription Factor Olig2 Genomic Binding Sites in Acutely Purified PDGFRα+ Cells by Low-cell Chromatin Immunoprecipitation Sequencing Analysis
Published on: April 16, 2018
Related Concept Videos
Notch Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Master Transcription Regulators
Master Transcription Regulators
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...